Brief: Algernon Pharmaceuticals Announces Receipt Of CAD$2 Mln Cash Refund From Australian Research Program
21/10/2021 12:28
Oct 21 (Reuters) - Algernon Pharmaceuticals Inc AGN.CD :
* ALGERNON PHARMACEUTICALS ANNOUNCES RECEIPT OF CAD$2M CASH
REFUND
FROM AUSTRALIAN RESEARCH PROGRAM AND FILES APPLICATION TO LIST
ITS COMMON SHARES ON NASDAQ CAPITAL MARKET
Source text for Eikon: ID:nGNX27qQ2x
Further company coverage: AGN.CD
((reuters.briefs@thomsonreuters.com;))
Recent news on Grey Matters Health
See all newsBrief: Grey Matters Announces The Closing Of Its Equity And Convertible Debenture Private Placement Totalling CAD $1.12 Million
Brief: Algernon Announces Additional Increase To Private Placement Financing
Brief: Algernon Health Announces Private Placement
Brief: Algernon Announces Closing Of The Private Placement Financing
Brief: Algernon Announces $1 Mln Private Placement